Table 1 Demographic and clinical characteristics of 63 individuals recruited classified in 3 groups.
| Â | Group ofCOPD+PAH (n = 12) | Group of COPD (n = 36) | Group of HS (n = 15) |
|---|---|---|---|
Sex, M/F | 11/1 | 32/4 | 9/6 |
Age, Years | 70.8 (6.7) | 67.6 (9.2) | 58 (9.2) |
Smoking, pack-years | 27 (7) | 25 (6) | 0 |
FEV1% | 39.35 (11.45) | 48.13 (18.04) | 98.05 (11.65) |
FVC% | 64.89 (14.90) | 69.39 (19.1) | 95.07 (13.34) |
FEV1/FVC % | 46.95 (6.81) | 54.27 (12.46) | 101.37 (8.5) |
RV% | 151 (38) | 143 (32) | 108 (11) |
PaO2 (mmHg) | 60.83 (4.76) | 64.58 (6.16) | 97.2 (0.7) |
PaCO2 (mmHg) | 39.4 (4.27) | 41.78 (5.01) | 38.4 (1.5) |
PaPs (mmHg) | 51.08 (12.2)* | 26.05 (3.39) | NA |
ET-1 EBC (pg/ml) | 22.36 (4) | 7.25 (0.23) | 5.24 (0.47) |
ET-1 art (pg/ml) | 12.41 (2.13) | 7.22 (0.21) | 0.84 (0.37) |
ET-1 ven (pg/ml) | 14.53 (2.76) | 7.29 (0.16) | 1 (0.42) |
FENO (ppb) | 22.92 (11.38) | 35.07 (17.53) | 20.56 (3.67) |
6MWD | 383 (34)§ | NA | NA |